RIN Institute Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
7
RIN Institute General Information
Description
Developer of antibody drugs designed for the diagnosis and treatment of cancer. The company's drugs develop antibody seeds that help in the development of cancer therapeutics and diagnostics, enabling doctors to cure various types of cancers, like breast cancer and ovarian cancer, using drugs and therapeutics, and provide patients with further chances for recovery.
Contact Information
Website
www.rinmab.co.jpCorporate Office
- 2nd Floor Success Ginza East Building
- 1-13-10 Tsukiji, Chuo-ku
- Tokyo, Chuo-ku 104-0045
- Japan
Corporate Office
- 2nd Floor Success Ginza East Building
- 1-13-10 Tsukiji, Chuo-ku
- Tokyo, Chuo-ku 104-0045
- Japan
RIN Institute Timeline
RIN Institute Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 03-Sep-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 31-May-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 30-Jun-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 04-Dec-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 23-May-2019 | $1.82M | $1.82M | Completed | Startup | |
| 1. University Spin-Out | 21-Jan-2016 | Completed | Generating Revenue |
RIN Institute Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| C Preferred | ||||||||
| B Preferred | 67,000 | $21.87 | $21.87 | 1x | $21.87 | 11.21% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
RIN Institute Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
RIN Institute Patents
RIN Institute Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026116345-A1 | Antibody-drug conjugate (adc) having linker comprising vlk peptide, and pharmaceutical composition comprising said adc | Pending | 27-Nov-2024 | ||
| WO-2025178058-A1 | Fibrin-binding antibody, fibrinolytic protein containing said antibody, and medicinal preparation containing said protein | Pending | 19-Feb-2024 | ||
| EP-4506458-A1 | Antibody binding to fibrin, fibrinolytic protein containing antibody, and pharmaceutical formulation containing protein | Inactive | 08-Apr-2022 | ||
| US-20260250366-A1 | Antibody binding to fibrin, fibrinolytic protein containing antibody, and pharmaceutical formulation containing protein | Pending | 08-Apr-2022 | ||
| WO-2023195535-A1 | Antibody binding to fibrin, fibrinolytic protein containing antibody, and pharmaceutical formulation containing protein | Inactive | 08-Apr-2022 | C12N9/6462 |
RIN Institute Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
RIN Institute Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MEDISO | Accelerator/Incubator | |||
| Alfresa Holdings | Corporation | Minority | ||
| Mitsubishi UFJ Capital | Venture Capital | Minority | ||
| UTokyo Innovation Platform | Accelerator/Incubator | Minority | ||
| Fast Track Initiative | Venture Capital | Minority |
RIN Institute Investments (1)
RIN Institute’s most recent deal was a University Spin-Out with Cast Bio. The deal was made on 30-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cast Bio | 30-Mar-2026 | University Spin-Out | Drug Discovery |
RIN Institute FAQs
-
When was RIN Institute founded?
RIN Institute was founded in 2016.
-
Where is RIN Institute headquartered?
RIN Institute is headquartered in Tokyo, Japan.
-
What is the size of RIN Institute?
RIN Institute has 3 total employees.
-
What industry is RIN Institute in?
RIN Institute’s primary industry is Drug Discovery.
-
Is RIN Institute a private or public company?
RIN Institute is a Private company.
-
What is RIN Institute’s current revenue?
The current revenue for RIN Institute is .
-
How much funding has RIN Institute raised over time?
RIN Institute has raised $9.3M.
-
Who are RIN Institute’s investors?
MEDISO, Alfresa Holdings, Mitsubishi UFJ Capital, UTokyo Innovation Platform, and Fast Track Initiative are 5 of 7 investors who have invested in RIN Institute.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
